Comparative review of topical ophthalmic antibacterial preparations

Drugs

Volumn 61, Issue 2, 2001, Pages 175-185

  Robert, P Y ^a   Adenis, J P ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACITRACIN; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; ERYTHROMYCIN; EYE DROPS; FUSIDIC ACID; GENTAMICIN; NEOMYCIN; NORFLOXACIN; OFLOXACIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMYCIN; SULFANILAMIDE DERIVATIVE; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BLOOD TOXICITY; COST BENEFIT ANALYSIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; EYE INFECTION; EYE TOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; PREGNANCY COMPLICATION; REVIEW; TRACHOMA;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 0035093477     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161020-00003     Document Type: Review

References (65)

1. Aminoglycosides
2. Aminioglycoside-aminocyclitol antibiotics and their modifying enzymes
3. The quinolones: Mode of action and bacterial resistance
4. Quinolones
5. Acide Fusidique
6. Bacterial resistance to other antibacterial agents
7. Tetracyclines
8. Emerging bacterial resistance: Real and relative
9. Ciprofloxacin resistant keratitis
10. Ciprofloxacin-resistant keratitis
11. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis to newer and established topical antibiotics
12. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates
13. Intraocular penetration of topical norfloxacin in humans: Preliminary study
14. Ocular penetration of topically applied norfloxacin 0.3% in the rabbits and in humans
15. Topical 0.3% ciprofloxacin, norfloxacin and ofloxacin in treatment of bacterial keratitis: A new method for comparative evaluation of ocular drug penetration
16. Aqueous humor concentration of the quinolone norfloxacin after local administration
17. Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora
18. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor
19. Penetration of norfloxacin into the aqueous humor of the human eye
20. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye
21. Retinal safety of oral and topical ofloxacin in rabbits
22. Corneal penetration of various aminoglycosides and quinolones
23. Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin
24. Corneal stromal penetration of topical ciprofloxacin in humans
25. Comparison of aqueous humor and vitreous human levels of two 0.3% ciprofloxacin eyedrops
26. Aqueous and vitreous penetration of levofloxacin after oral administration
27. Characterization of the carrier-mediated transprot of leveofloxacin, a fluoroquinolone antimicrobial agent, in rabbit cornea
28. Cultured rabbit corneal epithelium elicits levofloxacin absorption and secretion
29. Penetration of gentamycin into the aphakic eye
30. Gentamycin penetration and decay in the human aqueous
31. Ocular penetration of topically applied gentamycin
32. Antimicrobial efficacy and aqueous humor concentration of preoperative and post-operative topical trimethoprim/polymyxin B sulfate versus tobramycin
33. Use of collagen corneal shields in the treatment of bacterial keratitis
34. No detectable systemic absorption of topically administered ophthalmic tobramycin
35. Intraocular penetration of fusidic acid with topical fucithalmic
36. Pharmacokinetic investigation of fusidic acid 1% viscous eye drops in healthy volunteers
37. Ocular pharmacokinetics of thiamphenicol in rabbits
38. Systemic absorption of tipocally applied chloramphenicol eyedrops
39. Corneal penetration of rifampin
40. Intraocular penetration of vancomycin
41. Incidence of hypersensitivity to antibiotics and preservatives in eye drops [in Polish]
42. Contact allergy to components in topical ophthalmologic preparations
43. Antibiotics and corneal epithelial wound healing
44. Aminoglycoside toxicity in the treatment of endophthalmitis: The aminoglycoside toxicity study group
45. Pseudomembranous conjunctivitis following topical gentamycin therapy
46. Is it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasia
47. Chloramphenicol eyedrops and marrow aplasia
48. Fatal aplastic anaemia following topical administration of ophthalmic chloramphenicol
49. Use of chloramphenicol as topical eye medication: Time to cry halt?
50. Is it time to stop using chloramphenicol on the eye? General practitioners would expect to see aplasia roughly once each century
51. Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer
52. Is it time to stop using chloramphenicol on the eye? Risk is low in short courses
53. Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases
54. Chloramphenicol eye drops: A dangerous drug?
55. Ocular chloramphenicol and aplastic anaemia: Is there a link?
56. Safety of chloramphenicol eyedrops
57. It is time to stop using topical chloramphenicol?
58. Drug-induced fatal aplastic anaemia following cataract surgery
59. Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database
60. Blood dyscrasias and topical ophthalmic chloramphenicol
61. Insuffisance médullaire aplasie médullaire et autres affections primitives de la moelle osseuse
62. Use of ophthalmic medications in pregnant and nursing women
63. Cost effectiveness and cost utility of preventing trachomatous visual impairment: Lessons from 30 years of trachoma control in Burma